The European Medicines Agency (EMA) has approved Moderna for the coronavirus vaccine in adolescents aged 12 and older. The regulator announced this on Friday, July 23, in Amsterdam.
According to the statement, the benefits of the vaccine, which has so far been allowed to be given to people aged 18 and over, outweigh the risks associated with its use. The final decision on its use must now be taken by the European Commission. However, in this case, the last word of this EU body is considered a formality.
Since the end of May 2021, the Biontech & Pfizer vaccine has also been approved for use in the EU for children and adolescents aged 12 years and older. However, Germany’s Standing Vaccination Commission (Stiko) currently only recommends it to adolescents who suffer from certain chronic diseases.